Examiner Profile: MCKNIGHT, CIARA A - Patent Office Action Stats

Examiner: MCKNIGHT, CIARA A

Tech Center 1700 • Art Units: 1637 1647 1656 1799

This examiner grants 59% of resolved cases

Performance Statistics

59.2%

Allow Rate

-5.8% vs TC avg

103

Total Applications

+38.1%

Interview Lift

1155

Avg Prosecution Days

Based on 71 resolved cases, 2023–2026

4.3%

§101 Eligibility

15.0%

§102 Novelty

37.5%

§103 Obviousness

32.9%

§112 Clarity

App #	Title	Status	Assignee
18482052	NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING	Non-Final OA	UNIVERSITY OF MASSACHUSETTS
18514280	MODIFIED CELLS FOR THE PRODUCTION OF A RECOMBINANT PRODUCT OF INTEREST	Non-Final OA	Genentech, Inc.
18922889	PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF	Non-Final OA	Halozyme, Inc.
18175809	MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY	Non-Final OA	Regeneron Pharmaceuticals, Inc.
18175914	MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY	Non-Final OA	Regeneron Pharmaceuticals, Inc.
18165620	METHOD OF PRODUCING HYDROGEN PEROXIDE USING MICROORGANISM OF THE GENUS DESEMZIA	Final Rejection	Gwangju Institute of Science and Technology
18391959	ENGINEERED PROTEINS AND METHODS OF USE THEREOF	Final Rejection	Pairwise Plants Services, Inc.
17777245	COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION	Non-Final OA	THE CHILDREN'S HOSPITAL OF PHILADELPHIA

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.